⌘K

Login Start Free

Home/Filings/4/0001213900-19-026997

4//SEC Filing

Knie Robb 4

Accession 0001213900-19-026997

CIK 0001711786other

View on SEC.gov Company Profile

Filed

Dec 25, 7:00 PM ET

Accepted

Dec 26, 4:17 PM ET

Size

5.3 KB

Accession

0001213900-19-026997

Insider Transaction Report

Form 4

Period: 2019-12-24

Hoth Therapeutics, Inc.HOTH

DirectorCEO and President

Transactions

Other
Options
2019-12-24+250,000→ 250,000 total
Exercise: $5.26From: 2019-12-24Exp: 2029-12-24→ Common Stock (250,000 underlying)

Footnotes (1)

[F1]The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Hoth Therapeutics, Inc.

CIK 0001711786

Entity typeother

Related Parties

1

filerCIK 0001609695

Filing Metadata

Form type: 4
Filed: Dec 25, 7:00 PM ET
Accepted: Dec 26, 4:17 PM ET
Size: 5.3 KB

View on SEC.gov